This is a small company that was fought very hard by big pharma companies to destroy, but they could not. And then, BAM, something big happened: THE OPIOIDS EPIDEMICS, where pharma companies are now being sued for distributing pain killers and opioids like candies.
The RISE OF BIEL:
After many many years of fighting the FDA to get approval, the FDA approved the Actipatch for knee and foot for over the counter sale. The FDA bended the rules and Biel was first to be approved for Over the Counter. The rule making was intended for CLASS II prescription and not for Over the Counter.
Then recently as you know, the product entered the UK NHS reimbursement system and B. Braun, a multi billion, multi national company picked up the product for post surgery recovery.
Now Biel has a meeting with the FDA to approve the Actipatch for back pain and general muscle and joint pain. They should have done that back in 2017 but did not. Now Biel has a clinical trial on back pain with good results to persuade them.
Smart Insole is another approved product under licensing agreement.
Allay for menstrual pain clinical trial has been completed by the end of March and the migraines clinical trial will be completed by the end of this month.
You can do more DD and wait until it is less risky to invest in Biel. There is nothing wrong with that. However, you will miss the opportunity to maximize your profit. So, it is a risk/reward analysis.
Do as much DD as you can. I can guarantee you one thing. Your conclusion is going to be no less than SLAP THE ASK PRETTY HARD.
Think About It
News 
Market Data 
Discover 
AI
